Gufic Biosciences Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Gufic Biosciences heeft een totaal eigen vermogen van ₹5.7B en een totale schuld van ₹2.8B, wat de schuld-eigenvermogensverhouding op 49.4% brengt. De totale activa en totale passiva bedragen respectievelijk ₹11.0B en ₹5.3B. De EBIT Gufic Biosciences is ₹1.3B waardoor de rentedekking 9 is. Het heeft contanten en kortetermijnbeleggingen van ₹194.0M.
Belangrijke informatie
49.4%
Verhouding schuld/eigen vermogen
₹2.84b
Schuld
| Rente dekkingsratio | 9x |
| Contant | ₹193.96m |
| Aandelen | ₹5.74b |
| Totaal verplichtingen | ₹5.30b |
| Totaal activa | ₹11.05b |
Recente financiële gezondheidsupdates
Is Gufic Biosciences (NSE:GUFICBIO) Using Too Much Debt?
Jun 17
These 4 Measures Indicate That Gufic Biosciences (NSE:GUFICBIO) Is Using Debt Reasonably Well
Sep 02Gufic Biosciences (NSE:GUFICBIO) Has A Pretty Healthy Balance Sheet
Feb 11Gufic Biosciences (NSE:GUFICBIO) Has A Somewhat Strained Balance Sheet
Nov 13Recent updates
There's Reason For Concern Over Gufic Biosciences Limited's (NSE:GUFICBIO) Massive 26% Price Jump
Nov 07We Think You Should Be Aware Of Some Concerning Factors In Gufic Biosciences' (NSE:GUFICBIO) Earnings
Jun 06Is Gufic Biosciences (NSE:GUFICBIO) Using Too Much Debt?
Jun 17These 4 Measures Indicate That Gufic Biosciences (NSE:GUFICBIO) Is Using Debt Reasonably Well
Sep 02Should You Be Adding Gufic Biosciences (NSE:GUFICBIO) To Your Watchlist Today?
May 07Here's Why I Think Gufic Biosciences (NSE:GUFICBIO) Is An Interesting Stock
Dec 07This Is The Reason Why We Think Gufic Biosciences Limited's (NSE:GUFICBIO) CEO Might Be Underpaid
Sep 15Is Now The Time To Put Gufic Biosciences (NSE:GUFICBIO) On Your Watchlist?
Aug 12Gufic Biosciences' (NSE:GUFICBIO) Performance Is Even Better Than Its Earnings Suggest
Jun 11If You Like EPS Growth Then Check Out Gufic Biosciences (NSE:GUFICBIO) Before It's Too Late
Mar 19What Percentage Of Gufic Biosciences Limited (NSE:GUFICBIO) Shares Do Insiders Own?
Mar 01Gufic Biosciences (NSE:GUFICBIO) Has A Pretty Healthy Balance Sheet
Feb 11Is Gufic Biosciences' (NSE:GUFICBIO) 164% Share Price Increase Well Justified?
Jan 23
Why Gufic Biosciences Limited (NSE:GUFICBIO) Looks Like A Quality Company
Jan 05Here's Why I Think Gufic Biosciences (NSE:GUFICBIO) Is An Interesting Stock
Dec 18Here's What Gufic Biosciences Limited's (NSE:GUFICBIO) Shareholder Ownership Structure Looks Like
Dec 01Gufic Biosciences (NSE:GUFICBIO) Has A Somewhat Strained Balance Sheet
Nov 13The Gufic Biosciences (NSE:GUFICBIO) Share Price Has Gained 116%, So Why Not Pay It Some Attention?
Oct 19Can Gufic Biosciences Limited's (NSE:GUFICBIO) ROE Continue To Surpass The Industry Average?
Sep 14I Built A List Of Growing Companies And Gufic Biosciences (NSE:GUFICBIO) Made The Cut
Aug 24Investors Appear Satisfied With Gufic Biosciences Limited's (NSE:GUFICBIO) Prospects
Aug 03Earnings Tell The Story For Gufic Biosciences Limited (NSE:GUFICBIO)
Jul 09Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( ₹5.8B ) GUFICBIO } overtreffen de korte termijn passiva ( ₹3.5B ).
Langlopende schulden: De kortetermijnactiva GUFICBIO ( ₹5.8B ) overtreffen de langetermijnschulden ( ₹1.8B ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 46% ) GUFICBIO wordt als hoog beschouwd.
Schuld verminderen: De schuld/eigen vermogen-ratio van GUFICBIO is de afgelopen 5 jaar gedaald van 123.8% naar 49.4%.
Schuldendekking: De schuld van GUFICBIO wordt goed gedekt door de operationele kasstroom ( 24.6% ).
Rentedekking: De rentebetalingen op de schuld van GUFICBIO worden goed gedekt door EBIT ( 9 x dekking).